Author Archives: april@madhedgefundtrader.com

Accumulation You Can Taste

Remember that scene in The Big Short where everyone thinks Michael Burry’s lost his mind betting against housing? That’s exactly how I felt last week at a biotech conference in Boston when I suggested Merck (MRK) might be the most mispriced asset in big pharma. The room went dead quiet. One PM actually choked on […]

China Tech Delivers A.I. Value

Eighty percent of AI startups in the venture capitalist portfolios rely on Chinese open-source models, and that has to be one of the most important revelations of late in the AI bubble. We are at a crossroads as stocks like Nvidia are $4.5 trillion and counting. Some of these Chinese AI agents are such as […]

Shunned By Sentiment, Supported by Science

I look for situations where the risk-reward is skewed heavily in one direction. Amgen (AMGN) just set up that exact scenario with their Q3 earnings. Strong revenue growth, broad product momentum, attractive valuation, and a market that’s already priced in the worst-case scenario. When you find quality trading cheaply because of overblown fears, you’ve found […]